MGNX CIK: 1125345

MacroGenics Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
74.8
FY22:
149
FY23:
58.1
FY24:
149
FY25:
150
(positive)
Change from FY21 to FY25
millions USD
FY21:
−203
FY22:
−121
FY23:
−168
FY24:
−111
FY25:
−72.8
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−120
FY23:
−9.06
FY24:
−66.0
FY25:
−75.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−202
FY22:
−120
FY23:
−9.06
FY24:
−67.0
FY25:
−74.6

All amounts in millions USD Data source:SEC EDGAR